Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
~ Strategic Review Completed to Refocus Pipeline, Reduce Operating Costs and Deliver Long-Term Shareholder Value~ Updated Clinical Data on AMT-060 in Hemophilia B at Upcoming ASH Annual...
-
~ Strategic Review Completed to Refocus Pipeline, Reduce Operating Costs and Deliver Long-Term Shareholder Value ~ Updated Clinical Data on AMT-060 in Hemophilia B at Upcoming ASH Annual...
-
~ Company Structure Simplified; Manufacturing to be Consolidated into Lexington, MA ~ Preparation Underway for Late-Stage Development in Hemophilia B ~ Cost Savings Expected to Extend Cash Resources...
-
– Poster presentation on Saturday, December 3, 2016 – – Investor breakfast event on Monday, December 5 at 7:00 am PST/10:00 am EST – LEXINGTON, Mass. and AMSTERDAM, the Netherlands,...